US FDA takes steps to make 'compassionate use' easier
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has taken steps to make it easier for patients with serious or immediately life-threatening illnesses to be treated under the agency's expanded access, or compassionate use, program1-3.